Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sciclone Pharmaceut (SCLN)

Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 581,918
  • Shares Outstanding, K 52,190
  • Annual Sales, $ 160,100 K
  • Annual Income, $ 30,730 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.72
  • Price/Sales 3.63
  • Price/Cash Flow 14.83
  • Price/Book 2.31
  • Price/Earnings ttm 12.25
  • Earnings Per Share ttm 0.91
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.19
  • Growth Rate Est. (year over year) +525,689.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.02 +1.13%
on 09/15/17
11.20 -0.45%
on 10/13/17
+0.05 (+0.45%)
since 09/13/17
3-Month
10.90 +2.29%
on 08/02/17
11.43 -2.41%
on 08/03/17
+0.22 (+2.06%)
since 07/13/17
52-Week
8.55 +30.41%
on 10/28/16
11.43 -2.41%
on 08/03/17
+1.13 (+11.28%)
since 10/13/16

Business Summary

Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 11.22
1st Resistance Point 11.18
Last Price 11.15
1st Support Level 11.13
2nd Support Level 11.12
3rd Support Level N/A

See More

52-Week High 11.43
Last Price 11.15
Fibonacci 61.8% 10.33
Fibonacci 50% 9.99
Fibonacci 38.2% 9.65
52-Week Low 8.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar